Sleep Disorder Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Sleep Disorder Treatment Market Revenue and it is Segmented by Drug Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, and Other Drug Types), Application (Insomnia, Sleep Apnea, Narcolepsy, Circadian disorders, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Sleep Disorder Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Sleep Disorder Treatment Industry Overview

The sleep disorders market is moderately fragmented, with several manufacturers offering generics. Although few players offer branded drugs, price sensitivity is an issue in several regions. Companies focus on developing new chemical entities and novel molecules to obtain a higher revenue share. The major players include companies such as Takeda Pharmaceuticals USA Inc., Vanda Pharmaceuticals Inc., Merck & Co., Mylan NV, Pfizer, and Teva Pharmaceuticals USA Inc.

Sleep Disorder Treatment Market Leaders

  1. Merck & Co

  2. Mylan N.V.

  3. Pfizer

  4. Takeda Pharmaceutical Company Limited

  5. Teva Pharmaceutical Industries Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Sleep Disorders Treatment Market Concentration